194 related articles for article (PubMed ID: 30844885)
1. New approaches in salivary gland carcinoma.
Even C; Baste N; Classe M
Curr Opin Oncol; 2019 May; 31(3):169-174. PubMed ID: 30844885
[TBL] [Abstract][Full Text] [Related]
2. Salivary gland carcinoma: Towards a more personalised approach.
Rached L; Saleh K; Casiraghi O; Even C
Cancer Treat Rev; 2024 Mar; 124():102697. PubMed ID: 38401478
[TBL] [Abstract][Full Text] [Related]
3. A molecular guide to systemic therapy in salivary gland carcinoma.
Weaver AN; Lakritz S; Mandair D; Ulanja MB; Bowles DW
Head Neck; 2023 May; 45(5):1315-1326. PubMed ID: 36859797
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and therapeutic implications of new molecular biomarkers in salivary gland cancers.
Stenman G; Persson F; Andersson MK
Oral Oncol; 2014 Aug; 50(8):683-90. PubMed ID: 24856188
[TBL] [Abstract][Full Text] [Related]
5. [Tumor microenvironment in salivary gland carcinomas: Consequences for new therapeutic concepts].
Meyer MF; Arolt C; Kansy BA; Doescher J; Quaas A; Beutner D; Lang S; Klußmann JP
HNO; 2020 Dec; 68(12):927-934. PubMed ID: 32929519
[TBL] [Abstract][Full Text] [Related]
6. Mutational and immunologic Landscape in malignant Salivary Gland Tumors harbor the potential for novel therapeutic strategies.
Witte HM; Gebauer N; Steinestel K
Crit Rev Oncol Hematol; 2022 Feb; 170():103592. PubMed ID: 35026433
[TBL] [Abstract][Full Text] [Related]
7. Advances and challenges in precision medicine in salivary gland cancer.
Lassche G; van Boxtel W; Ligtenberg MJL; van Engen-van Grunsven ACH; van Herpen CML
Cancer Treat Rev; 2019 Nov; 80():101906. PubMed ID: 31644971
[TBL] [Abstract][Full Text] [Related]
8. Dynamic Role of miRNAs in Salivary Gland Carcinomas: From Biomarkers to Therapeutic Targets.
Kimura TC; de Lima-Souza RA; Maciel TF; Kowalski LP; Coutinho-Camillo CM; Egal ESA; Altemani A; Mariano FV
Head Neck Pathol; 2024 Feb; 18(1):12. PubMed ID: 38393615
[TBL] [Abstract][Full Text] [Related]
9. Concomitant expression of ezrin and HER2 predicts distant metastasis and poor prognosis of patients with salivary gland carcinomas.
Hashimoto K; Hayashi R; Mukaigawa T; Yamazaki M; Fujii S
Hum Pathol; 2017 May; 63():110-119. PubMed ID: 28300573
[TBL] [Abstract][Full Text] [Related]
10. Current State of Knowledge on Salivary Gland Cancers.
Lin HH; Limesand KH; Ann DK
Crit Rev Oncog; 2018; 23(3-4):139-151. PubMed ID: 30311570
[TBL] [Abstract][Full Text] [Related]
11. Genomics in non-adenoid cystic group of salivary gland cancers: one or more druggable entities?
Cavalieri S; Platini F; Bergamini C; Resteghini C; Galbiati D; Bossi P; Perrone F; Tamborini E; Quattrone P; Licitra L; Locati LD; Alfieri S
Expert Opin Investig Drugs; 2019 May; 28(5):435-443. PubMed ID: 30897975
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical and molecular profile of salivary gland cancer in children.
Locati LD; Collini P; Imbimbo M; Barisella M; Testi A; Licitra LF; Löning T; Tiemann K; Quattrone P; Bimbatti E; Chiaravalli S; Casanova M; Tamborini E; Carta R; Gasparini P; Guzzo M; Massimino M; Ferrari A
Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28139061
[TBL] [Abstract][Full Text] [Related]
13. Exploring Immunological Effects and Novel Immune Adjuvants in Immunotherapy for Salivary Gland Cancers.
Sato R; Yamaki H; Komatsuda H; Wakisaka R; Inoue T; Kumai T; Takahara M
Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539539
[TBL] [Abstract][Full Text] [Related]
14. Biology and management of salivary gland cancers.
Adelstein DJ; Koyfman SA; El-Naggar AK; Hanna EY
Semin Radiat Oncol; 2012 Jul; 22(3):245-53. PubMed ID: 22687949
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneous impact of smoking on major salivary gland cancer according to histopathological subtype: A case-control study.
Sawabe M; Ito H; Takahara T; Oze I; Kawakita D; Yatabe Y; Hasegawa Y; Murakami S; Matsuo K
Cancer; 2018 Jan; 124(1):118-124. PubMed ID: 28881386
[TBL] [Abstract][Full Text] [Related]
16. Programmed death ligand-1 expression is associated with poor disease free survival in salivary gland carcinomas.
Mukaigawa T; Hayashi R; Hashimoto K; Ugumori T; Hato N; Fujii S
J Surg Oncol; 2016 Jul; 114(1):36-43. PubMed ID: 27111278
[TBL] [Abstract][Full Text] [Related]
17. Systemic therapy in metastatic salivary gland carcinomas: A pathology-driven paradigm?
Alfieri S; Granata R; Bergamini C; Resteghini C; Bossi P; Licitra LF; Locati LD
Oral Oncol; 2017 Mar; 66():58-63. PubMed ID: 28249649
[TBL] [Abstract][Full Text] [Related]
18. Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs).
Locati LD; Perrone F; Losa M; Mela M; Casieri P; Orsenigo M; Cortelazzi B; Negri T; Tamborini E; Quattrone P; Bossi P; Rinaldi G; Bergamini C; Calderone RG; Liberatoscioli C; Licitra L
Oral Oncol; 2009 Nov; 45(11):986-90. PubMed ID: 19574086
[TBL] [Abstract][Full Text] [Related]
19. Management of salivary gland carcinomas - a review.
Wang X; Luo Y; Li M; Yan H; Sun M; Fan T
Oncotarget; 2017 Jan; 8(3):3946-3956. PubMed ID: 27992367
[TBL] [Abstract][Full Text] [Related]
20. Management of salivary gland malignancies in the pediatric population.
Aro K; Leivo I; Mäkitie A
Curr Opin Otolaryngol Head Neck Surg; 2014 Apr; 22(2):116-20. PubMed ID: 24419404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
